Search

Search Constraints

You searched for: Author/Creator Tanaka, Saiyu

Search Results

1. A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers. Issue 5 (25th August 2015)

2. Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non‐alcoholic fatty liver disease. (12th May 2020)

3. Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis. Issue 9 (6th March 2019)

4. Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non‐alcoholic fatty liver disease patients. Issue 5 (9th June 2020)

5. Development of hepatocellular carcinoma in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression. Issue 11 (15th December 2016)

6. Effect of 12‐week dulaglutide therapy in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease and type 2 diabetes mellitus. Issue 11 (5th December 2016)

7. Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non‐alcoholic fatty liver disease and type 2 diabetes mellitus. Issue 10 (7th December 2016)

8. Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma. Issue 13 (2nd April 2014)

9. HOMA‐IR: An independent predictor of advanced liver fibrosis in nondiabetic non‐alcoholic fatty liver disease. Issue 8 (3rd February 2019)

10. Human placental extract treatment for non‐alcoholic steatohepatitis non‐responsive to lifestyle intervention: A pilot study. Issue 9 (12th November 2014)